Phase IV Study of FDA Approved, Once-Daily GRALISE™(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia
Public ClinicalTrials.gov record NCT01426230. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Open Label, Study of Safety and Effectiveness of GRALISE™(Gabapentin) Tablets in the Treatment of Patients With Postherpetic Neuralgia in Clinical Practice
Study identification
- NCT ID
- NCT01426230
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Depomed
- Industry
- Enrollment
- 201 participants
Conditions and interventions
Conditions
Interventions
Not listed
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2011
- Primary completion
- Feb 29, 2012
- Completion
- Mar 31, 2012
- Last update posted
- Mar 20, 2013
2011 – 2012
United States locations
- U.S. sites
- 37
- U.S. states
- 19
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Mobile | Alabama | — | — |
| Not listed | Tuscaloosa | Alabama | — | — |
| Not listed | Phoenix | Arizona | — | — |
| Not listed | Sun City | Arizona | — | — |
| Not listed | Tucson | Arizona | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | San Francisco | California | — | — |
| Not listed | Fairfield | Connecticut | — | — |
| Not listed | Lauderdale Lakes | Florida | — | — |
| Not listed | Naples | Florida | — | — |
| Not listed | North Palm Beach | Florida | — | — |
| Not listed | Ormond Beach | Florida | — | — |
| Not listed | Palm Beach | Florida | — | — |
| Not listed | Sunrise | Florida | — | — |
| Not listed | Marietta | Georgia | — | — |
| Not listed | Bolingbrook | Illinois | — | — |
| Not listed | Evansville | Indiana | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Brighton | Massachusetts | — | — |
| Not listed | Worcestor | Massachusetts | — | — |
| Not listed | Jefferson City | Missouri | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Tom River | New Jersey | — | — |
| Not listed | Hickory | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Allentown | Pennsylvania | — | — |
| Not listed | Altoona | Pennsylvania | — | — |
| Not listed | Wyomissing | Pennsylvania | — | — |
| Not listed | Mt. Pleasant | South Carolina | — | — |
| Not listed | Cordova | Tennessee | — | — |
| Not listed | Austin | Texas | — | — |
| Not listed | Bedford | Texas | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Orem | Utah | — | — |
| Not listed | Edmonds | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01426230, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 20, 2013 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01426230 live on ClinicalTrials.gov.